ADPT Adaptive Biotechnologies Corp: Earnings per share for the last twelve months
A full staff of leading bioinformaticians provides the technological breakthrough for Adaptive Biotechnologies (ADPT). Tracking the trailing twelve-month net income per share on GURU.Markets, we note that -0.45 shows the level of this metric. This success is based on physician recognition of ultra-precise tests and management's transparent approach to implementing immunological platforms.
Analytical breakdowns and data insights for company Adaptive Biotech (ADPT)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Liabilities to Capital|Short-Term Debt to Capital Adaptive Biotechnologies Corp|ADPT - Company Aggregate Debts|Debts to Book Capitalization Adaptive Biotechnologies Corporation|ADPT - Company Long-Term Indebtedness|Company Short-Term Debts Adaptive Biotechnologies|Quick Liquidity adaptivebiotech.com
- earnings and valuation multiples indicators:
ADPT - Profit After Tax|Future Profit Adaptive Biotechnologies|ADPT - Market Price to Net Income Ratio|Forward P/E Multiple Adaptive Biotechnologies Corporation|ADPT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Adaptive Biotechnologies Corporation|ADPT - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Adaptive Biotechnologies|ADPT - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months adaptivebiotech.com|ADPT - Earnings per share increase in current year|Earnings growth forecast for next year Adaptive Biotechnologies
Analysis of all company metrics:Adaptive Biotechnologies (ADPT)
From a portfolio management perspective, this indicator reflects the actual net income per share over a trailing twelve-month period, allowing for an objective business valuation without distortions from quarterly lags. By analyzing the EPS TTM history, an investor can gauge the effectiveness of Adaptive Biotechnologies (ADPT) current pivot toward break-even through cost optimization and the commercialization of immunosequencing.
Direct competitors
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Net earnings per one share for the last twelve months|BioCryst Pharmaceuticals Inc - Net earnings per share (EPS TTM)|VERA - Net earnings per share (EPS TTM)|DNTH: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PHVS|ABCL (AbCellera Biologics Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Tourmaline Bio Inc|Earnings per share for the last twelve months Intrexon (PGEN)|PHAR: Earnings per one share for the last 12 months|Nektar Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the last four quarters UPB (upstreambio.com)|Zenas Biopharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Immunome Inc IMNM|GOSS (Gossamer Corp) - Net earnings per share for the last 12 months|KALV (KalVista Corp) - Earnings per share for the last twelve months|SEPN (Septerna Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months pieris.com PVLA|Net earnings per share for the last 12 months SVRA (Savara)|RIGL (Rigel Pharma) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ANAB (AnaptysBio Corp)|Astria Corp - Earnings per share for the last twelve months|enGene Holdings Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters RAPT Therapeutics Inc. RAPT|aerovatetx.com (JBIO) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Aclaris Therapeutics Inc. (ACRS)|Net earnings per share for the last 12 months KYTX|TLSA (Tiziana Life Sciences, Ltd.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) CABA|VTYX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THTX (Theratechnologies)|AVTX - Net earnings per share for the last 12 months|Eledon - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AGEN (Agenus, Inc)|Climb Bio Inc (CLYM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ZURA|Earnings per share for the last twelve months aTyr Pharma|Net earnings per one share for the last twelve months Adagene Corp ADAG|Earnings per share for the last twelve months ImageneBio Inc (IMA)|Earnings per share for the last twelve months STTK (shattucklabs.com)|Earnings per share for the last twelve months Equillium EQ|Connect Biopharma Holdings (CNTB) - Net earnings per one share for the last twelve months|Immunic Inc - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Atara Biotherapeutics (ATRA)|IFRX: Net earnings per share (EPS TTM)|XFOR - Net earnings per share for the last four quarters|ACET (Adicet Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Celularity Corp CELU|Earnings per share for the last twelve months INmune Bio (INMB)|Net earnings per share for the last four quarters Barinthus Biotherapeutics PLC|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|Net earnings per share (EPS TTM) SAB Biotherapeutics Inc SABS|Akari Therapeutics - Net earnings per share (EPS TTM)|ENLV (Enlivex Therapeutics) - Earnings per share for the last 12 months|q32bio.com (QTTB) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months GOVX (GeoVax Labs)|Net earnings per share for the last 12 months EDSA|IBIO (iBio Corporation) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|XTLB: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics, Inc.)|Earnings per share for the trailing year HCWB|Aptevo - Net earnings per share (EPS TTM)|AIM - Net earnings per share (EPS TTM)|aditxt.com (ADTX) - Earnings per share for the last twelve months|gribio.com - Earnings per share for the trailing year|Earnings per share for the last twelve months XORTX Therapeutics|Net earnings per share for the last 12 months Vyome Holdings Inc. (HIND)|Net earnings per share (EPS TTM) REVB|Net earnings per share (EPS TTM) Indaptus Corp (INDP)|Scinai Immunotherapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year CALI|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Allakos Inc. ALLK|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months IGM Biosciences|Earnings per share for the last twelve months iTeos Therapeutics|Net earnings per share for the last 12 months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TCBP (TC BioPharm)|Net earnings per share (EPS TTM) Third Harmonic Bio Inc. (THRD)
